NDC 0641-6115-01 - Oxytocin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6115
- Requested NDC
- 0641-6115-01
- Package NDCs from labels
- 0641-6115-01, 0641-6115-25
- Manufacturer
- Hikma Pharmaceuticals USA Inc. | Gland Pharma Limited
- Effective date
- 2019-12-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Oxytocin - Hikma Pharmaceuticals USA Inc. | Gland Pharma Limited | Hikma Pharmaceuticals USA Inc. | Gland Pharma Limited | 2019-12-30 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0641-6115-25 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-7f27-d83d-e063-dadaa90ab31f | Oxytocin Injection, USP (synthetic) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6115-01 | Oxytocin | 10 mL in 1 VIAL | INJECTION | 10 | 3 | |
| 0641-6115-25 | Oxytocin | 25 in 1 CARTON | INJECTION | 25 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6115-01 | ML - Milliliter | 0641-6115 | 5f654325-5d51-43d3-b685-4d6acf0d0ba6 | 1 | 2012-07-24 |
| 0641-6115-25 | ML - Milliliter | 0641-6115 | 1b040dc4-4b03-4b77-8542-19857f1c0ec1 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| OXYTOCIN | ACTIVE INGREDIENT | 1JQS135EYN | OXYTOCIN INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| OXYTOCIN | ACTIVE MOIETY | 1JQS135EYN | OXYTOCIN INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| ACETIC ACID | INACTIVE INGREDIENT | Q40Q9N063P | OXYTOCIN INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| CHLOROBUTANOL | INACTIVE INGREDIENT | HM4YQM8WRC | OXYTOCIN INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | OXYTOCIN INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sterile Water | WATER | Asclemed USA, Inc. | 45c38269-883c-4198-a9d5-03810a4420ec | 2021-01-14 | Warnings, Adverse reactions | 059QF0KO0R |
| Bach Original Flower Remedies | WATER | Nelson Bach USA Limited | 09c76050-42c5-4403-865c-a1f6f668d9c0 | 2020-06-15 | Warnings | 059QF0KO0R |
| 43bde17d-d249-4ad7-9136-a4ecd9dc648d | a9b62187-4141-487c-a9da-f42ad7f9b408 | 2019-12-30 | Boxed warning, Warnings, Adverse reactions | 43bde17d-d249-4ad7-9136-a4ecd9dc648d a9b62187-4141-487c-a9da-f42ad7f9b408 | ||
| Sterile Water | WATER | Baxter Healthcare Company | 8bcf5572-49e1-4302-9522-56f57904cb4a | 2019-12-29 | Warnings, Adverse reactions | 059QF0KO0R |
| GUNA-GERIATRICS | 1,4-BENZOQUINONE - ARNICA MONTANA - OXYTOCIN - BARIUM CARBONATE - BARIUM OXALOSUCCINATE - CORTICOTROPIN - LEAD - LEVOTHYROXINE - LUTRELIN - MALIC ACID - MELATONIN - NEUROTROPHIN-3 - NEUROTROPHIN-4 - PHENYLALANINE - PORK LIVER - PYRUVIC ACID - RINFABATE - SUS SCROFA ADRENAL GLAND - SUS SCROFA FRONTAL LOBE - SUS SCROFA HYPOTHALAMUS - THYROTROPIN ALFA - BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN - | Guna spa | 03dc86d3-575f-4c65-b06d-2613efbcd943 | 2018-12-22 | Warnings | 1JQS135EYN |
| Dynamic Eyewash with Eyecup | WATER | Dynamic Safety International | 7d3af0f4-0e1f-9ea5-e053-2991aa0af7a2 | 2018-12-17 | Warnings | 059QF0KO0R |
| Oxytocin | OXYTOCIN | West-Ward Pharmaceuticals Corp | d16a48c5-6b71-40a0-bcda-204f043fe832 | 2018-12-14 | Boxed warning, Warnings, Adverse reactions | 1791721 238013 1JQS135EYN |
| Bio Rock Water | ROCK WATER | BioActive Nutritional, Inc. | 178bd16d-0d4f-49d8-866b-8ab3a3c6889d | 2018-07-30 | Warnings | 059QF0KO0R |
| Acetic Acid | ACETIC ACID | Baxter Healthcare Corporation | 41bc12af-fac5-4ac1-b907-dcb3e35a054c | 2018-02-02 | Warnings, Adverse reactions | Q40Q9N063P |
| Homeoplex D | GLYCERINUM, PHYTOLACCA DECANDRA, TARAXACUM OFFICINALE, ARSENICUM ALBUM, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETYLSALICYLICUM ACIDUM, GLONOINUM, INSULINUM (SUIS), LITHIUM CARBONICUM, THYROIDINUM (SUIS), SALICYLICUM ACIDUM, ADRENOCORTICOTROPHIN, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, SORBITOL, RESORCINUM, BENZYL ALCOHOL, LACTICUM ACIDUM, ISOPROPYL PALMITATE, BORICUM ACIDUM, ACETICUM ACIDUM, | Supplement Clinic, LLC. | cd6b48ab-3566-484d-8deb-15ef6f8e7e8f | 2017-11-01 | Warnings | Q40Q9N063P |
| Glucose Control T015 | SYZYGIUM JAMBOLANUM, GLANDULA SUPRARENALIS SUIS, HYDRASTIS CANADENSIS, HYPOPHYSIS SUIS, PANCREAS SUIS, PHASEOLUS, ACETICUM ACIDUM, LACTICUM ACIDUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, URANIUM NITRICUM | Guangzhou Renuma Medical Systems Co., Ltd | 3fd02c0a-5cf1-4f35-86d0-d5d09e63f39b | 2017-10-26 | Warnings | Q40Q9N063P |
| Sterile Water | WATER | Baxter Healthcare Corporation | ef3e79c5-3f58-4b36-a296-64b7d9a651c1 | 2017-10-17 | Warnings, Adverse reactions | 059QF0KO0R |
| Eye Wash | WATER | CVS Pharmacy | 049cee29-7ec2-4d5b-8308-f522acde43a7 | 2017-03-29 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Baxter Healthcare Company | 210dc9ab-d6ca-4552-ac19-1be17792d290 | 2016-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.